IBio Is Maintained at Buy by Chardan Capital
IBio Is Maintained at Buy by Chardan Capital
Chardan Capital Maintains Buy on IBio, Maintains $5 Price Target
Chardan Capital analyst Keay Nakae maintains iBio with a Buy and maintains $5 price target.
Express News | Ibio Closes Sale of Manufacturing Facility in Texas
IBio Initiated at Buy by Chardan Capital
IBio Initiated at Buy by Chardan Capital
IBio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/28/2024 121.24% Chardan Capital → $5 Initiates Coverage On → Buy 02/16/2023 — JMP Securities Downgrade
Express News | Ibio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $5
Chardan Research Starts IBio With Buy Rating, $5 Price Target
Chardan Research Starts iBio With Buy Rating, $5 Price Target.
Express News | Ibio Inc - Purchase and Sale Agreement Provides That Property Will Be Sold to Board of Regents for a Purchase Price of $8.5 Mln
Express News | Ibio Inc - Ibio CDMO LLC Entered Into Purchase, Sale Agreement, Dated as of May 17, With Board of Regents of Texas a&M University System
IBio Reports Q3 Results
iBio Inc | 10-Q: Quarterly report
Express News | IBio Q3 EPS $(0.71) Up From $(9.53) YoY
IBio 3Q Rev $0 >IBIO
IBio 3Q Rev $0 >IBIO
Express News | Ibio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
Express News | IBio Files Prospectus Relates To Resale From Time To Time Of Up To 10.6M Shares Of Common Stock By Selling Stockholders
Express News | Ibio Inc -Files Prospectus Relates to Resale From Time to Time of up to 10.6 Mln Shares of Common Stock by Selling Stockholders
IBio Inc. Raises $15M in Private Placement and Issues Warrants
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO
IBio, Mesoblast, Kodiak Sciences Among Healthcare Movers
Trending Stocks Today: Avalo Therapeutics Surges 340% Pre-Market
March 28th - US stocks trending pre-market: Gainers: $Avalo Therapeutics(AVTX.US)$ surges 340% to $20.9 with a turnover of $19.54 million. $Kidpik(PIK.US)$ shoots up 63.91% to $5.36 with a turnover of